Cel Sci (CVM) Notes Payables (2010 - 2021)
Cel Sci (CVM) posted Notes Payables of $2195.0 for Q4 2021, down 99.5% sequentially from $437380.0 in Q3 2021, and down 99.89% YoY from $2.0 million in Q4 2020.
Cel Sci (CVM) Notes Payables (2010 - 2021) Analysis & Trends
Cel Sci has reported Notes Payables for 8 years, with the latest figure at $2195.0 in Q4 2021.
- Quarterly Notes Payables fell 99.89% year-over-year to $2195.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2195.0 (down 99.89% YoY) and the FY2021 annual result came in at $437380.0, up 104.59% from the prior year.
- Notes Payables eased to $2195.0 in Q4 2021 per CVM's latest filing, from $437380.0 in the prior quarter.
- Over five years, Notes Payables peaked at $2.5 million in Q3 2018 and troughed at $2195.0 in Q4 2021.
- A 5-year average of $881879.0 and a median of $555911.0 in 2019 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2019 and 2021: Notes Payables soared 25323.82% in 2019, then slumped 99.89% in 2021.
- Over 5 years, Notes Payables stood at $19724.0 in 2017, then jumped by 12567.85% to $2.5 million in 2018, then tumbled by 53.51% to $1.2 million in 2019, then surged by 75.69% to $2.0 million in 2020, then sank by 99.89% to $2195.0 in 2021.
- According to Business Quant data, Notes Payables over the past three periods registered $2195.0, $437380.0, and $918704.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2,195.00 |
| Sep 30, 2021 | 437,380.00 |
| Jun 30, 2021 | 918,704.00 |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | 2.04 Mn |
| Sep 30, 2020 | 213,787.00 |
| Jun 30, 2020 | 1.92 Mn |
| Mar 31, 2020 | 2.16 Mn |
| Dec 31, 2019 | 1.16 Mn |
| Sep 30, 2019 | 674,442.00 |
| Jun 30, 2019 | 1.25 Mn |
| Sep 30, 2018 | 2.50 Mn |
| Jun 30, 2018 | 4,916.00 |
| Mar 31, 2018 | 20,919.00 |
| Dec 31, 2017 | 19,724.00 |
| Sep 30, 2017 | 10,984.00 |
| Jun 30, 2017 | 47,894.00 |
| Mar 31, 2017 | 208,493.00 |
| Dec 31, 2016 | 249,157.00 |
| Dec 31, 2011 | 30,912.00 |